Orientational Disorder in Adamantane and Adamantanecarboxylic Acid

The molecular crystals adamantane, C10H16, and adamantanecarboxylic acid, C10H15COOH, undergo order–disorder phase transitions at 208 and 250 K, respectively. Reverse Monte Carlo refinement of total neutron scattering data collected from deuterated samples immediately above these phase transitions s...

Full description

Saved in:
Bibliographic Details
Published in:Chemphyschem 2017-03, Vol.18 (5), p.459-464
Main Authors: Beake, Edward O. R., Tucker, Matthew G., Dove, Martin T., Phillips, Anthony E.
Format: Article
Language:English
Subjects:
adamantane
Neutrons
orientational disorder
Phase transitions
plastic crystals
reverse Monte Carlo
total neutron scattering
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The molecular crystals adamantane, C10H16, and adamantanecarboxylic acid, C10H15COOH, undergo order–disorder phase transitions at 208 and 250 K, respectively. Reverse Monte Carlo refinement of total neutron scattering data collected from deuterated samples immediately above these phase transitions shows that the high‐temperature phases are well described by models in which the adamantyl groups are disordered over two sites. No correlation between the orientations of neighbouring molecules is observed. These results demonstrate that the intermolecular potential energy of these materials depends strongly on the orientation of the reference molecule but only very weakly on the orientations of its neighbours. Short‐sighted: Total neutron scattering data reveal no correlation between the orientations of neighbouring molecules in the disordered phases of adamantane or adamantanecarboxylic acid. Despite the high molecular symmetry, reverse Monte Carlo refinement from initially random molecular orientations shows that these orientations in both materials follow a strongly bimodal distribution (shown for adamantane in figure).
ISSN:1439-4235
1439-7641
DOI:10.1002/cphc.201601219